These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10195629)

  • 1. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide.
    Sturgess AW; Rush K; Charbonneau RJ; Lee JI; West DJ; Sitrin RD; Hennessy JP
    Vaccine; 1999 Mar; 17(9-10):1169-78. PubMed ID: 10195629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability testing in Haemophilus influenzae type b conjugate vaccines.
    Klug B
    Dev Biol Stand; 1996; 87():263-7. PubMed ID: 8854026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Donnelly JJ; Deck RR; Liu MA
    J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths.
    Rana R; Dalal J; Singh D; Kumar N; Hanif S; Joshi N; Chhikara MK
    Vaccine; 2015 May; 33(23):2646-54. PubMed ID: 25907408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages.
    Ambrosino DM; Bolon D; Collard H; Van Etten R; Kanchana MV; Finberg RW
    J Immunol; 1992 Dec; 149(12):3978-83. PubMed ID: 1460286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative study on saccharide quantification of the
    Rosskopf U; Daas A; Terao E; von Hunolstein C
    Pharmeur Bio Sci Notes; 2017; 2017():44-68. PubMed ID: 29017702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine.
    Guo YY; Anderson R; McIver J; Gupta RK; Siber GR
    Biologicals; 1998 Mar; 26(1):33-8. PubMed ID: 9637747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
    Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity characterization of bromoacetyl derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by NMR spectroscopy.
    Rustandi RR; Xu Q
    Vaccine; 2022 Jan; 40(2):187-191. PubMed ID: 34893342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children.
    Harrison LH; Tajkowski C; Croll J; Reid R; Hu D; Brenneman G; Weatherholtz RC; Santosham M
    J Pediatr; 1994 Oct; 125(4):571-6. PubMed ID: 7931875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection.
    Tsai CM; Gu XX; Byrd RA
    Vaccine; 1994 Jun; 12(8):700-6. PubMed ID: 8091847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines.
    Costantino P; Norelli F; Giannozzi A; D'Ascenzi S; Bartoloni A; Kaur S; Tang D; Seid R; Viti S; Paffetti R; Bigio M; Pennatini C; Averani G; Guarnieri V; Gallo E; Ravenscroft N; Lazzeroni C; Rappuoli R; Ceccarini C
    Vaccine; 1999 Mar; 17(9-10):1251-63. PubMed ID: 10195638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
    Plumb JE; Yost SE
    Vaccine; 1996 Apr; 14(5):399-404. PubMed ID: 8735551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children.
    Lehmann D; Kakazo M; Yarsley S; Javati A; Taime J; Saleu G; Namuigi P; Alpers MP; Mendelman PM; Staub T
    P N G Med J; 1998; 41(3-4):102-11. PubMed ID: 10934551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of low level unconjugated polysaccharide in tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HCl.
    Lei QP; Lamb DH; Heller R; Pietrobon P
    J Pharm Biomed Anal; 2000 Jan; 21(6):1087-91. PubMed ID: 10708393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.
    Halperin SA; Langley JM; Hesley TM; Zappacosta PS; Radley D; Smith B; Hoffenbach A; Boslego J; Silber JL
    Hum Vaccin; 2005; 1(6):245-50. PubMed ID: 17012871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
    Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
    J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.